Houlihan Lokey Advises Acteon

Houlihan Lokey is pleased to announce the refinancing of Acteon, a leading global dental healthcare platform and multi-specialist medtech group serving dental professionals in more than 120 countries. The transaction closed on 23 July 2026.

Founded in 2003, Acteon has established a leading position in dental imaging, specialised equipment, and pharmaceutical solutions, supported by a strong portfolio of premium brands, recurring revenue streams, and a global distribution footprint. Acteon is owned by Dentressangle, the family investment holding company of entrepreneur Norbert Dentressangle, which pursues a long-term investment strategy focused on supporting high-quality businesses with sustainable growth prospects. The group generates over €250 million of revenue.

The transaction refinances Acteon’s existing unitranche facilities provided by CAPZA and LGT, delivering a more efficient and scalable capital structure. The new €194.0 million syndicated financing package comprises a €164.0 million Term Loan B with a 100% bullet repayment profile and a €30.0 million multi-purpose revolving credit facility, providing additional liquidity and financial flexibility.

This refinancing significantly reduces Acteon’s financial interest expenses and provides substantial capacity to support the group’s continued organic development, operational initiatives, and strategic opportunities.

The transaction further illustrates Houlihan Lokey’s long-standing partnership with Dentressangle and Acteon. Following its role as advisor on Acteon’s refinancing in 2023 and on the acquisition of a strategic stake in Inibsa in 2024, the firm is delighted to have supported the group once again in this landmark refinancing.* This continued collaboration highlights the strength of its relationship with the shareholder and management team, as well as the firm’s ability to accompany clients throughout their M&A and financing journey.

If you would like more information about Houlihan Lokey or have questions regarding the firm’s role in this transaction, please contact the deal team members listed below.

*Selected transactions were executed by Houlihan Lokey professionals while at other firms acquired by Houlihan Lokey or by professionals from a Houlihan Lokey joint venture company.

RELATED: Healthcare, Healthcare Technology, Capital Solutions